Recent Advances on the Prevention and Management of Rheumatic Heart Disease

Jiawen Zhang; Songhao Jia; Yuhe Chen; Jie Han; Hongjia Zhang; Wenjian Jiang

doi:10.5334/gh.1402

Recent Advances on the Prevention and Management of Rheumatic Heart Disease

Global Heart

Volume 20 (2025): Issue 1

By: Jiawen Zhang , Songhao Jia , Yuhe Chen , Jie Han, Hongjia Zhang and Wenjian Jiang

Open Access

|Feb 2025

Ou Z, Yu D, Liang Y, et al. Global burden of rheumatic heart disease: Trends from 1990 to 2019. Arthritis Res Ther. 2022; 24(1):138. DOI: 10.1186/s13075-022-02829-3
Open DOI Search in Google Scholar Back to article
Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25):2982–3021. DOI: 10.1016/j.jacc.2020.11.010
Open DOI Search in Google Scholar Back to article
Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N Engl J Med. 2017; 377(8):713–722. DOI: 10.1056/NEJMoa1603693
Open DOI Search in Google Scholar Back to article
Hibino M, Halkos ME, Murphy DA, et al. Age period cohort analysis of rheumatic heart disease in high-income countries. Clin Res Cardiol. 2023; 112(11):1568–1576. DOI: 10.1007/s00392-023-02168-6
Open DOI Search in Google Scholar Back to article
Safiri S, Mousavi SE, Noori M, et al. The burden of rheumatic heart disease in the Middle East and North Africa region, 1990–2019. Arch Cardiovasc Dis. 2023; 116(12):542–554. DOI: 10.1016/j.acvd.2023.09.005
Open DOI Search in Google Scholar Back to article
Guan C, Xu W, Wu S, Zhang J. Rheumatic heart disease burden, trends, and inequalities in Asia, 1990–2019. Glob Health Action. 2023; 16(1):2215011. DOI: 10.1080/16549716.2023.2215011
Open DOI Search in Google Scholar Back to article
Coffey PM, Ralph AP, Krause VL. The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review. PLoS Negl Trop Dis. 2018; 12(6):e0006577. DOI: 10.1371/journal.pntd.0006577
Open DOI Search in Google Scholar Back to article
Steer AC. Historical aspects of rheumatic fever. J Paediatr Child Health. 2015; 51(1):21–27. DOI: 10.1111/jpc.12808
Open DOI Search in Google Scholar Back to article
Bach JF, Chalons S, Forier E, et al. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet. 1996; 347(9002):644–648. DOI: 10.1016/S0140-6736(96)91202-7
Open DOI Search in Google Scholar Back to article
Nordet P, Lopez R, Duenas A, Sarmiento L. Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986–1996–2002). Cardiovasc J Afr. 2008; 19(3):135–140. https://www.ncbi.nlm.nih.gov/pubmed/18568172. Published 2008/06/24
Search in Google Scholar Back to article
Bowen AC, Harris T, Holt DC, et al. Whole genome sequencing reveals extensive community-level transmission of group A Streptococcus in remote communities. Epidemiol Infect. 2016; 144(9):1991–1998. DOI: 10.1017/S095026881500326X
Open DOI Search in Google Scholar Back to article
Cordery R, Purba AK, Begum L, et al. Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: A prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK. Lancet Microbe. 2022; 3(5):e366–e375. DOI: 10.1016/S2666-5247(21)00332-3
Open DOI Search in Google Scholar Back to article
Bennett J, Zhang J, Leung W, et al. Rising ethnic inequalities in acute rheumatic fever and rheumatic heart disease, New Zealand, 2000–2018. Emerg Infect Dis. 2021; 27(1):36–46. DOI: 10.3201/eid2701.191791
Open DOI Search in Google Scholar Back to article
Whitcombe AL, McGregor R, Bennett J, et al. Increased breadth of group a streptococcus antibody responses in children with acute rheumatic fever compared to precursor pharyngitis and skin infections. J Infect Dis. 2022; 226(1):167–176. DOI: 10.1093/infdis/jiac043
Open DOI Search in Google Scholar Back to article
Rwebembera J, Cannon JW, Sanyahumbi A, et al. Research opportunities for the primary prevention and management of acute rheumatic fever and rheumatic heart disease: A National Heart, Lung, and Blood Institute workshop report. BMJ Glob Health. 2023; 8(Suppl 9). DOI: 10.1136/bmjgh-2023-012356
Open DOI Search in Google Scholar Back to article
Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord. 2005; 5(1):11. DOI: 10.1186/1471-2261-5-11
Open DOI Search in Google Scholar Back to article
Nalubwama H, Ndagire E, Sarnacki R, et al. Community perspectives on primary prevention of rheumatic heart disease in Uganda. Glob Heart. 2022; 17(1):5. DOI: 10.5334/gh.1094
Open DOI Search in Google Scholar Back to article
Parks T, Smeesters PR, Steer AC. Streptococcal skin infection and rheumatic heart disease. Curr Opin Infect Dis. 2012; 25(2):145–153. DOI: 10.1097/QCO.0b013e3283511d27
Open DOI Search in Google Scholar Back to article
Thornley S, Marshall R, Jarrett P, Sundborn G, Reynolds E, Schofield G. Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children. J Paediatr Child Health. 2018; 54(6):625–632. DOI: 10.1111/jpc.13851
Open DOI Search in Google Scholar Back to article
Coates MM, Sliwa K, Watkins DA, et al. An investment case for the prevention and management of rheumatic heart disease in the African Union 2021–30: A modelling study. Lancet Glob Health. 2021; 9(7):e957–e966. DOI: 10.1016/S2214-109X(21)00199-6
Open DOI Search in Google Scholar Back to article
Cannon JW, Wyber R. Modalities of group A streptococcal prevention and treatment and their economic justification. NPJ Vaccines. 2023; 8(1):59. DOI: 10.1038/s41541-023-00649-3
Open DOI Search in Google Scholar Back to article
Cohen JF, Bertille N, Cohen R, Chalumeau M. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev. 2016; 7(7):CD010502. DOI: 10.1002/14651858.CD010502.pub2
Open DOI Search in Google Scholar Back to article
Tortorice D, Ferranna M, Bloom DE. Optimal global spending for group A Streptococcus vaccine research and development. NPJ Vaccines. 2023; 8(1):62. DOI: 10.1038/s41541-023-00646-6
Open DOI Search in Google Scholar Back to article
Azuar A, Jin W, Mukaida S, Hussein WM, Toth I, Skwarczynski M. Recent advances in the development of peptide vaccines and their delivery systems against group A Streptococcus. Vaccines (Basel). 2019; 7(3). DOI: 10.3390/vaccines7030058
Open DOI Search in Google Scholar Back to article
Walker MJ, Barnett TC, McArthur JD, et al. Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clin Microbiol Rev. 2014; 27(2):264–301. DOI: 10.1128/CMR.00101-13
Open DOI Search in Google Scholar Back to article
Massell BF, Honikman LH, Amezcua J. Rheumatic fever following streptococcal vaccination. Report of three cases. JAMA. 1969; 207(6):1115–1119. https://www.ncbi.nlm.nih.gov/pubmed/5818242. Published 1969/02/10
Search in Google Scholar Back to article
Dale JB, Chiang EY, Lederer JW. Recombinant tetravalent group A streptococcal M protein vaccine. J Immunol. 1993; 151(4):2188–2194. https://www.ncbi.nlm.nih.gov/pubmed/8345202. Published 1993/08/15
Search in Google Scholar Back to article
Castro SA, Dorfmueller HC. A brief review on group A Streptococcus pathogenesis and vaccine development. R Soc Open Sci. 2021; 8(3):201991. DOI: 10.1098/rsos.201991
Open DOI Search in Google Scholar Back to article
Shea PR, Ewbank AL, Gonzalez-Lugo JH, et al. Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002–2010. Emerg Infect Dis. 2011; 17(11):2010–2017. DOI: 10.3201/eid1711.110159
Open DOI Search in Google Scholar Back to article
Davies MR, McIntyre L, Mutreja A, et al. Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics. Nat Genet. 2019; 51(6):1035–1043. DOI: 10.1038/s41588-019-0417-8
Open DOI Search in Google Scholar Back to article
Smeesters PR, McMillan DJ, Sriprakash KS, Georgousakis MM. Differences among group A streptococcus epidemiological landscapes: Consequences for M protein-based vaccines? Expert Rev Vaccines. 2009; 8(12):1705–1720. DOI: 10.1586/erv.09.133
Open DOI Search in Google Scholar Back to article
Dale JB, Walker MJ. Update on group A streptococcal vaccine development. Curr Opin Infect Dis. 2020; 33(3):244–250. DOI: 10.1097/QCO.0000000000000644
Open DOI Search in Google Scholar Back to article
Pastural E, McNeil SA, MacKinnon-Cameron D, et al. Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study. Vaccine. 2020; 38(6):1384–1392. DOI: 10.1016/j.vaccine.2019.12.005
Open DOI Search in Google Scholar Back to article
Sekuloski S, Batzloff MR, Griffin P, et al. Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial. PLoS One. 2018; 13(7):e0198658. DOI: 10.1371/journal.pone.0198658
Open DOI Search in Google Scholar Back to article
Dale JB, Aranha MP, Penfound TA, Salehi S, Smith JC. Structure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccine. Vaccine. 2023; 41(40):5841–5847. DOI: 10.1016/j.vaccine.2023.08.026
Open DOI Search in Google Scholar Back to article
Alharbi N, Shalash AO, Koirala P, et al. Cholesterol as an inbuilt immunoadjuvant for a lipopeptide vaccine against group A Streptococcus infection. J Colloid Interface Sci. 2024; 663:43–52. DOI: 10.1016/j.jcis.2024.02.134
Open DOI Search in Google Scholar Back to article
Pitirollo O, Di Benedetto R, Henriques P, et al. Elucidating the role of N-acetylglucosamine in group A Carbohydrate for the development of an effective glycoconjugate vaccine against group A Streptococcus. Carbohydr Polym. 2023; 311:120736. DOI: 10.1016/j.carbpol.2023.120736
Open DOI Search in Google Scholar Back to article
Gao NJ, Rodas Lima E, Nizet V. Immunobiology of the classical lancefield group A Streptococcal Carbohydrate Antigen. Infect Immun. 2021; 89(12):e0029221. DOI: 10.1128/IAI.00292-21
Open DOI Search in Google Scholar Back to article
Troese MJ, Burlet E, Cunningham MW, et al. Group A Streptococcus vaccine targeting the erythrogenic toxins SpeA and SpeB is safe and immunogenic in rabbits and does not induce antibodies associated with autoimmunity. Vaccines (Basel). 2023; 11(9). DOI: 10.3390/vaccines11091504
Open DOI Search in Google Scholar Back to article
Chen S, Ozberk V, Sam G, et al. Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus. NPJ Vaccines. 2023; 8(1):102. DOI: 10.1038/s41541-023-00695-x
Open DOI Search in Google Scholar Back to article
Fan J, Toth I, Stephenson RJ. Recent scientific advancements towards a vaccine against group A Streptococcus. Vaccines (Basel). 2024; 12(3). DOI: 10.3390/vaccines12030272
Open DOI Search in Google Scholar Back to article
Osowicki J, Vekemans J, Kaslow DC, Friede MH, Kim JH, Steer AC. WHO/IVI global stakeholder consultation on group A Streptococcus vaccine development: Report from a meeting held on 12–13 December 2016. Vaccine. 2018; 36(24):3397–3405. DOI: 10.1016/j.vaccine.2018.02.068
Open DOI Search in Google Scholar Back to article
Dougherty S, Okello E, Mwangi J, Kumar RK. Rheumatic heart disease: JACC focus seminar 2/4. J Am Coll Cardiol. 2023; 81(1):81–94. DOI: 10.1016/j.jacc.2022.09.050
Open DOI Search in Google Scholar Back to article
Rwebembera J, Marangou J, Mwita JC, et al. 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease. Nat Rev Cardiol. 2024; 21(4):250–263. DOI: 10.1038/s41569-023-00940-9
Open DOI Search in Google Scholar Back to article
Francis JR, Whalley GA, Kaethner A, et al. Single-view echocardiography by nonexpert practitioners to detect rheumatic heart disease: A prospective study of diagnostic accuracy. Circ Cardiovasc Imaging. 2021; 14(8):e011790. DOI: 10.1161/CIRCIMAGING.120.011790
Open DOI Search in Google Scholar Back to article
Francis JR, Fairhurst H, Yan J, et al. Abbreviated echocardiographic screening for rheumatic heart disease by nonexperts with and without offsite expert review: A diagnostic accuracy study. J Am Soc Echocardiogr. 2023; 36(7):733–745. DOI: 10.1016/j.echo.2023.02.007
Open DOI Search in Google Scholar Back to article
Elazrag A, Altahir A, Abbas A, et al. Handheld echocardiographic screening for rheumatic heart disease by non-experts in rural South Kordofan, Sudan: Supporting task shifting for control of a serious disease. Int J Cardiol. 2023; 377:99–103. DOI: 10.1016/j.ijcard.2023.01.024
Open DOI Search in Google Scholar Back to article
Peck D, Rwebembera J, Nakagaayi D, et al. The use of artificial intelligence guidance for rheumatic heart disease screening by novices. J Am Soc Echocardiogr. 2023; 36(7):724–732. DOI: 10.1016/j.echo.2023.03.001
Open DOI Search in Google Scholar Back to article
Edwards LA, Feng F, Iqbal M, et al. Machine learning for pediatric echocardiographic mitral regurgitation detection. J Am Soc Echocardiogr. 2023; 36(1):96–104 e104. DOI: 10.1016/j.echo.2022.09.017
Open DOI Search in Google Scholar Back to article
Martins J, Nascimento ER, Nascimento BR, et al. Towards automatic diagnosis of rheumatic heart disease on echocardiographic exams through video-based deep learning. J Am Med Inform Assoc. 2021; 28(9):1834–1842. DOI: 10.1093/jamia/ocab061
Open DOI Search in Google Scholar Back to article
Gurney J, Chong A, Culliford-Semmens N, Tilton E, Wilson NJ, Sarfati D. The benefits and harms of rheumatic heart disease screening from the perspective of the screened population. Int J Cardiol. 2016; 221:734–740. DOI: 10.1016/j.ijcard.2016.07.025
Open DOI Search in Google Scholar Back to article
Beaton A, Okello E, Rwebembera J, et al. Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease. N Engl J Med. 2022; 386(3):230–240. DOI: 10.1056/NEJMoa2102074
Open DOI Search in Google Scholar Back to article
de Dassel JL, de Klerk N, Carapetis JR, Ralph AP. How many doses make a difference? An analysis of secondary prevention of rheumatic fever and rheumatic heart disease. J Am Heart Assoc. 2018; 7(24):e010223. DOI: 10.1161/JAHA.118.010223
Open DOI Search in Google Scholar Back to article
Ralph AP, Noonan S, Wade V, Currie BJ. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Med J Aust. 2021; 214(5):220–227. DOI: 10.5694/mja2.50851
Open DOI Search in Google Scholar Back to article
Regmi PR, Dhungel M, Kafle R. Secondary prevention of rheumatic heart disease in nepal: Are we going backward? JNMA J Nepal Med Assoc. 2022; 60(253):832–835. DOI: 10.31729/jnma.7861
Open DOI Search in Google Scholar Back to article
Ambari AM, Radi B, Dwiputra B, et al. Adherence to penicillin treatment is essential for effective secondary prevention of rheumatic heart disease: a systematic review and meta-analysis. Ann Med Surg (Lond). 2024; 86(4):2116–2123. DOI: 10.1097/MS9.0000000000001833
Open DOI Search in Google Scholar Back to article
Longenecker CT, Morris SR, Aliku TO, et al. Rheumatic heart disease treatment cascade in Uganda. Circ Cardiovasc Qual Outcomes. 2017; 10(11). DOI: 10.1161/CIRCOUTCOMES.117.004037
Open DOI Search in Google Scholar Back to article
Fall N, Odong F, Thembo J, et al. User-centered design to develop automated short message service messaging for patient support of rheumatic heart disease secondary antibiotic prophylaxis. J Am Heart Assoc. 2024; 13(2):e031252. DOI: 10.1161/JAHA.123.031252
Open DOI Search in Google Scholar Back to article
Dixit J, Prinja S, Jyani G, et al. Evaluating efficiency and equity of prevention and control strategies for rheumatic fever and rheumatic heart disease in India: an extended cost-effectiveness analysis. Lancet Glob Health. 2023; 11(3):e445–e455. DOI: 10.1016/S2214-109X(22)00552-6
Open DOI Search in Google Scholar Back to article
Rwebembera J, Ndagire E, Carvalho N, et al. Intramuscular versus Enteral Penicillin Prophylaxis to Prevent Progression of Rheumatic Heart Disease: Study protocol for a non-inferiority randomized trial (the GOALIE trial). Am Heart J. 2024. DOI: 10.1016/j.ahj.2024.05.012
Open DOI Search in Google Scholar Back to article
Karthikeyan G, Kothari SS. How should the burden of rheumatic heart disease be reduced? Lancet Glob Health. 2023; 11(3):e316–e317. DOI: 10.1016/S2214-109X(23)00011-6
Open DOI Search in Google Scholar Back to article
Francia CJ, Fraser JF, Justo R, Cassimatis J, Manoy S, Johnston LM. Follow-up echocardiographic changes in children and youth aged >25 years with latent rheumatic heart disease: A systematic review and meta-analysis of global data. Int J Cardiol. 2024; 403:131911. DOI: 10.1016/j.ijcard.2024.131911
Open DOI Search in Google Scholar Back to article
Kim JY, Kim SH, Myong JP, et al. Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis. J Am Coll Cardiol. 2019; 73(10):1123–1131. DOI: 10.1016/j.jacc.2018.12.047
Open DOI Search in Google Scholar Back to article
Connolly SJ, Karthikeyan G, Ntsekhe M, et al. Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation. N Engl J Med. 2022; 387(11):978–988. DOI: 10.1056/NEJMoa2209051
Open DOI Search in Google Scholar Back to article
Mutagaywa RK, Kifai E, Elinisa M, et al. Comparison between interventional versus medical therapy in patients with rheumatic mitral valve stenosis in Tanzania. Eur J Clin Invest. 2024; 54(3):e14114. DOI: 10.1111/eci.14114
Open DOI Search in Google Scholar Back to article
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143(5):e72–e227. DOI: 10.1161/CIR.0000000000000923
Open DOI Search in Google Scholar Back to article
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7):561–632. DOI: 10.1093/eurheartj/ehab395
Open DOI Search in Google Scholar Back to article
Desnos C, Iung B, Himbert D, et al. Temporal Trends on Percutaneous Mitral Commissurotomy: 30 Years of Experience. J Am Heart Assoc. 2019; 8(13):e012031. DOI: 10.1161/JAHA.119.012031
Open DOI Search in Google Scholar Back to article
Ko KY, Cho I, Kim DY, et al. Optimizing Percutaneous Mitral Valvuloplasty for Rheumatic Mitral Stenosis – Clinical Significance of Changes in Mitral Valve Area. Circ J. 2024. DOI: 10.1253/circj.CJ-23-0552
Open DOI Search in Google Scholar Back to article
Yasmin F, Jawed S, Najeeb H, et al. Comparative efficacy and safety of mitral valve repair versus mitral valve replacement in Rheumatic heart disease: A high-value care systematic review and meta-analysis. Curr Probl Cardiol. 2024; 49(6):102530. DOI: 10.1016/j.cpcardiol.2024.102530
Open DOI Search in Google Scholar Back to article
Lee HA, Chang FC, Yeh JK, et al. Mitral valve repair vs. replacement by different etiologies – A nationwide population-based cohort study. Circ J. 2024; 88(4):568–578. DOI: 10.1253/circj.CJ-23-0640
Open DOI Search in Google Scholar Back to article
Sliwa K, Johnson MR, Zilla P, Roos-Hesselink JW. Management of valvular disease in pregnancy: A global perspective. Eur Heart J. 2015; 36(18):1078–1089. DOI: 10.1093/eurheartj/ehv050
Open DOI Search in Google Scholar Back to article
European Society of G, Association for European Paediatric C, German Society for Gender M, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011; 32(24):3147–3197. DOI: 10.1093/eurheartj/ehr218
Open DOI Search in Google Scholar Back to article
Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999; 33(6):1637–1641. DOI: 10.1016/S0735-1097(99)00044-3
Open DOI Search in Google Scholar Back to article
Pieper PG, Balci A, Van Dijk AP. Pregnancy in women with prosthetic heart valves. Neth Heart J. 2008; 16(12):406–411. DOI: 10.1007/BF03086187
Open DOI Search in Google Scholar Back to article
Elkayam U, Goland S. The search for a safe and effective anticoagulation regimen in pregnant women with mechanical prosthetic heart valves. J Am Coll Cardiol. 2012; 59(12):1116–1118. DOI: 10.1016/j.jacc.2011.12.018
Open DOI Search in Google Scholar Back to article
McLintock C, McCowan LM, North RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG. 2009; 116(12):1585–1592. DOI: 10.1111/j.1471-0528.2009.02299.x
Open DOI Search in Google Scholar Back to article
Chen CY, Chan YH, Wu VC, et al. Bioprosthetic versus mechanical mitral valve replacements in patients with rheumatic heart disease. J Thorac Cardiovasc Surg. 2023; 165(3):1050–1060 e1058. DOI: 10.1016/j.jtcvs.2021.03.033
Open DOI Search in Google Scholar Back to article
Zilla P, Human P, Pennel T. Mechanical valve replacement for patients with rheumatic heart disease: the reality of INR control in Africa and beyond. Front Cardiovasc Med. 2024; 11:1347838. DOI: 10.3389/fcvm.2024.1347838
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.5334/gh.1402 | Journal eISSN: 2211-8179

Journal RSS Feed

Language: English

Submitted on: Aug 27, 2024

Accepted on: Feb 7, 2025

Published on: Feb 21, 2025

Published by: Ubiquity Press

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

Rheumatic Heart Disease,

Prevention,

Vaccine,

Surgery,

Mitral Valve Repair

© 2025 Jiawen Zhang, Songhao Jia, Yuhe Chen, Jie Han, Hongjia Zhang, Wenjian Jiang, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 20 (2025): Issue 1